This presentation provides a practical, up-to-date overview of the evolving role of radiotherapy (RT) in the management of lymphoma, with a focus on emerging evidence and real-world clinical practice. Recent advances in systemic therapy, imaging, and radiotherapy techniques have reshaped how RT is integrated across lymphoma subtypes, disease stages, and treatment settings. The session reviews key data informing contemporary indications for RT, including consolidative, definitive, and salvage approaches, and discuss how these findings translate into everyday decisionmaking. Emphasis is placed on risk-adapted treatment strategies, modern target volume concepts, and dose optimization aimed at maintaining efficacy while minimizing toxicity. Practical considerations such as patient selection, timing of RT relative to systemic therapy, and challenges encountered in routine practice are highlighted through clinical scenarios. The talk also addresses areas of ongoing controversy and evolving practice, providing guidance on how to apply evidence in settings where data may be limited or patient factors complex. Overall, this session aims to equip clinicians with a pragmatic framework for delivering evidence-based, patient-centered radiotherapy for lymphoma in contemporary practice.